Quantitative phosphoproteomics reveals genistein as a modulator of cell cycle and DNA damage response pathways in triple-negative breast cancer cells

Around one sixth of breast cancer cases are classified as triple-negative breast cancer (TNBC), named after the absence of the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2); however, patients with TNBC suffer from poor clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: FANG, YI, ZHANG, QIAN, WANG, XIN, YANG, XUE, WANG, XIANGYU, HUANG, ZHEN, JIAO, YUCHEN, WANG, JING
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750531/
https://www.ncbi.nlm.nih.gov/pubmed/26783066
http://dx.doi.org/10.3892/ijo.2016.3327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750531/
https://www.ncbi.nlm.nih.gov/pubmed/26783066
http://dx.doi.org/10.3892/ijo.2016.3327

Ejemplares similares